NDC11 87143020030
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 87143-0200-30 | 87143-0200 |
| 87143-200-30 | 87143-200 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Trilitas | TAZAROTENE | Perfero Pharma, Inc. | 1cf1faef-73b8-4ab2-a4c8-521f0bd3fc10 | 2026-05-18 | Warnings, Adverse reactions | 87143-200-30 87143-200 87143020030 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.